Skip to content

A team for the integrated traditional Chinese and Western medicine diagnosis and treatment of infectious anorectal diseases

A study on the safety and efficacy of the Yinyang and Xue Detoxification Formula in the treatment of postoperative wounds in patients with yin deficiency and internal heat type of anorectal infectious diseases.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025002494
Enrollment
Unknown
Registered
2025-12-24
Start date
2025-08-06
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

After anal fistula surgery, after perianal abscess surgery

Interventions

control group:Kangfuxin Liquid for External Use Only
Experimental Group:Yangyin Hexue Jiedu Formula for Oral Administration

Sponsors

Wangjing Hospital China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Aged between 18 and 60 years old, regardless of gender (2) Meeting the diagnostic criteria of anal fistula and perianal abscess in both Chinese and Western medicine. (3) Having undergone anal fistulotomy or abscess incision. (4) Receiving anal surgery for the first time. (5) Voluntarily signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) Patients with severe cardiovascular or cerebrovascular diseases, hematological diseases, or malignant tumors who are unable to tolerate surgery; (3) Patients with neurological or psychiatric disorders, or those exhibiting poor compliance during screening who are unable to cooperate with the study; (4) Patients with conditions affecting wound healing, including diabetes, anemia, thyroid dysfunction, or those having taken hormones within the past 6 months; (5) Patients with abnormal liver or kidney function; (6) Patients who have used Chinese patent medicines or herbal formulations within 2 weeks prior to enrollment; (7) Patients deemed by clinicians as unsuitable for participation based on symptoms, signs, or auxiliary examination results;

Design outcomes

Primary

MeasureTime frame
Wound healing time;

Secondary

MeasureTime frame
Wound pain;The incidence of edema in granulation tissue of wounds;The incidence of ulceration in granulation tissue of wounds;

Countries

China

Contacts

Public ContactYuening Feng

Wangjing Hospital China Academy of Chinese Medical Sciences

fyn20051103@sina.com13716921518

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026